Torvast and hepatitis fulminant Patient Reports February 12, 2012

Torvast Side Effects Report #4677006-0
Torvast side effect was reported by a Physician from on May 17, 2005. Male patient, 67 years of age, was diagnosed with ill-defined disorder and was treated with Torvast. After drug was administered, patient experienced the following side effects: hepatitis fulminant, myopathy. Torvast dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with HALDOL, TEGRETOL, LAMICTAL, CLONAZEPAM, GARDENALE. Patient died on 05/09/2005.

Torvast Side Effects Report #4686383-6
Torvast side effect was reported by a Physician from on May 27, 2005. Male patient, 67 years of age, was diagnosed with ill-defined disorder and was treated with Torvast. After drug was administered, patient experienced the following side effects: chest injury, chromaturia, dyspnoea, epilepsy , haemoglobin decreased, hepatitis fulminant, hepatorenal syndrome, pneumonia , red blood cells urine positive. Torvast dosage: 20 MG (20 MG, 1 IN 1 D) ORAL. During the same period patient was treated with CITALOPRAM, HALDOL, TEGRETOL, LAMICTAL, CLONAZEPAM, GARDENALE. Patient was hospitalized. Patient died on 05/09/2005.